Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Robert E Landry

Director at Cytokinetics Inc (CYTK)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $147K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 15SEC CYTKCytokinetics Inc Sell Plan 1,0008,184 held (−11%) $72.13 $72K -14.1%
Sep 11SEC CYTKCytokinetics Inc Sell Plan 1,0009,184 held (−10%) $74.66 $75K -17.0%
  • Sell

    Director Robert E Landry sold $72K of CYTK at $72.13 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Robert E Landry sold $75K of CYTK at $74.66 — pre-scheduled 10b5-1 plan sale.